WeissLaw LLP: MedAssets, Inc. Acquisition By Pamplona Capital Management May Not Be In The Best Interest Of MDAS Shareholders

06 Nov, 2015, 14:55 ET from WeissLaw LLP

NEW YORK, Nov. 6, 2015 /PRNewswire/ -- The fairness of the proposed acquisition of MedAssets, Inc. ("MDAS" or the "Company") by Pamplona Capital Management ("Pamplona") is the subject of an investigation by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation is focusing on possible breaches of fiduciary duty and other violations of law by the Board of Directors of MDAS for agreeing to sell the Company to Pamplona. On November 2, 2015, the Company announced it had reached a definitive agreement for Pamplona to acquire all outstanding shares of MDAS in a transaction valued at approximately $2.7 billion, inclusive of debt. Under the terms of the agreement, MDAS shareholders will receive $31.35 in cash for each MDAS share they own. 

WeissLaw is investigating whether MDAS's Board acted to maximize shareholder value prior to entering into the agreement. Notably, the Company recently announced positive financial results for the third quarter of 2015. It reported total net revenues of $190.0 million as compared with $175.7 million in the same period of the previous year, representing an increase of $14.3 million year-over-year.

Given these facts, WeissLaw is investigating whether MDAS's Board acted in the best interests of MDAS's public shareholders by actively shopping the Company to maximize shareholder value prior to entering into the agreement with Pamplona. If you own MDAS shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin or Kelly Keenan by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/contact/report_fraud/.

Attorney Advertising.  Past results do not guarantee a similar outcome.

 

SOURCE WeissLaw LLP



RELATED LINKS

http://www.weisslurie.com